These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 35532312)

  • 1. The Nocebo Response in Pharmacologic Treatments of Primary Headache: A Systematic Review and Meta-Analysis.
    Zhang Y; Xu Y; Liu S; Liang J; Fan S; Ding M; Wang J; Xiao Z
    J Clin Pharmacol; 2022 Oct; 62(10):1257-1272. PubMed ID: 35532312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nocebo in headache.
    Mitsikostas DD
    Curr Opin Neurol; 2016 Jun; 29(3):331-6. PubMed ID: 26926672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nocebo response in human models of migraine: A systematic review and meta-analysis of randomized, double-blind, placebo-controlled, two-way crossover trials in migraine without aura and healthy volunteers.
    Ghanizada H; Iljazi A; Ashina H; Do TP; Al-Karagholi MA; Amin FM; Ashina M
    Cephalalgia; 2021 Jan; 41(1):99-111. PubMed ID: 33241720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nocebo is the enemy, not placebo. A meta-analysis of reported side effects after placebo treatment in headaches.
    Mitsikostas DD; Mantonakis LI; Chalarakis NG
    Cephalalgia; 2011 Apr; 31(5):550-61. PubMed ID: 21216874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nocebo Response in the Pharmacological Management of Overactive Bladder: A Systematic Review and Meta-analysis.
    Mostafaei H; Mori K; Quhal F; Miura N; Motlagh RS; Pradere B; Laukhtina E; Lysenko I; Ghaffari S; Hajebrahimi S; Shariat SF
    Eur Urol Focus; 2021 Sep; 7(5):1143-1156. PubMed ID: 33153953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Examining the Nocebo Effect in Trials of Neuromodulators for Use in Disorders of Gut-Brain Interaction.
    Glissen Brown JR; Sanayei A; Proctor S; Flanagan R; Ballou S; Bain PA; Nee J
    Am J Gastroenterol; 2023 Apr; 118(4):692-701. PubMed ID: 36563308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nocebo in headaches: implications for clinical practice and trial design.
    Mitsikostas DD
    Curr Neurol Neurosci Rep; 2012 Apr; 12(2):132-7. PubMed ID: 22193945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-analysis of placebo-arm dropouts in osteoporosis randomized-controlled trials and implications for nocebo-associated discontinuation of anti-osteoporotic drugs in clinical practice.
    Kravvariti E; Kasdagli MI; Diomatari KM; Mouratidou P; Daskalakis K; Mitsikostas DD; Sfikakis PP; Yavropoulou MP
    Osteoporos Int; 2023 Mar; 34(3):585-598. PubMed ID: 36596944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acupuncture for the prevention of episodic migraine.
    Linde K; Allais G; Brinkhaus B; Fei Y; Mehring M; Vertosick EA; Vickers A; White AR
    Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD001218. PubMed ID: 27351677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Placebo and nocebo responses in randomised, controlled trials of medications for ADHD: a systematic review and meta-analysis.
    Faraone SV; Newcorn JH; Cipriani A; Brandeis D; Kaiser A; Hohmann S; Haege A; Cortese S
    Mol Psychiatry; 2022 Jan; 27(1):212-219. PubMed ID: 33972692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program.
    Dodick DW; Turkel CC; DeGryse RE; Aurora SK; Silberstein SD; Lipton RB; Diener HC; Brin MF;
    Headache; 2010 Jun; 50(6):921-36. PubMed ID: 20487038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxins for the prevention of migraine in adults.
    Herd CP; Tomlinson CL; Rick C; Scotton WJ; Edwards J; Ives N; Clarke CE; Sinclair A
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD011616. PubMed ID: 29939406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Placebo and nocebo effects in the neurological practice.
    Bittar C; Nascimento OJ
    Arq Neuropsiquiatr; 2015 Jan; 73(1):58-63. PubMed ID: 25608129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nocebo response intensity and influencing factors in the randomized clinical trials of irritable bowel syndrome: A systematic review and meta-analysis.
    Li R; Chen F; He X; Feng Y; Pei Q; Wang D; Liu X; Liu J; Hou X; Bai T
    Front Med (Lausanne); 2022; 9():1018713. PubMed ID: 36606047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study.
    Dodick DW; Mauskop A; Elkind AH; DeGryse R; Brin MF; Silberstein SD;
    Headache; 2005 Apr; 45(4):315-24. PubMed ID: 15836567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiepileptics other than gabapentin, pregabalin, topiramate, and valproate for the prophylaxis of episodic migraine in adults.
    Linde M; Mulleners WM; Chronicle EP; McCrory DC
    Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD010608. PubMed ID: 23797674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nocebo response in Parkinson's disease: A systematic review and meta-analysis.
    Leal Rato M; Duarte GS; Ferreira AN; Alves M; Mainoli B; Teodoro T; Mestre TA; Costa J; Ferreira JJ
    Parkinsonism Relat Disord; 2019 Aug; 65():13-19. PubMed ID: 31103487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nocebo Response in Attention Deficit Hyperactivity Disorder: Meta-Analysis and Meta-Regression of 105 Randomized Clinical Trials.
    Ramírez-Saco D; Barcheni M; Cunill R; Sáez M; Farré M; Castells X
    J Atten Disord; 2022 Sep; 26(11):1412-1421. PubMed ID: 35102771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sumatriptan-naproxen and butalbital: a double-blind, placebo-controlled crossover study.
    Derosier F; Sheftell F; Silberstein S; Cady R; Ruoff G; Krishen A; Peykamian M
    Headache; 2012 Apr; 52(4):530-43. PubMed ID: 22103635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Placebo and nocebo responses in restless legs syndrome: A systematic review and meta-analysis.
    Silva MA; Duarte GS; Camara R; Rodrigues FB; Fernandes RM; Abreu D; Mestre T; Costa J; Trenkwalder C; Ferreira JJ
    Neurology; 2017 Jun; 88(23):2216-2224. PubMed ID: 28490647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.